Your browser doesn't support javascript.
loading
Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model.
Khaki Bakhtiarvand, Vahid; Ramezani-Ali Akbari, Khadijeh; Amir Jalali, Seyed; Hojjat-Farsangi, Mohammad; Jeddi-Tehrani, Mahmood; Shokri, Fazel; Shabani, Mahdi.
Afiliação
  • Khaki Bakhtiarvand V; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ramezani-Ali Akbari K; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Amir Jalali S; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hojjat-Farsangi M; Department of Oncology-Pathology, BioClinicum Karolinska University Hospital Solna and Karolinska Institute, 17164 Stockholm, Sweden.
  • Jeddi-Tehrani M; Monoclonal Antibody Research Centre, Avicenna Research Institute (ACECR), Tehran, Iran.
  • Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Shabani M; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: msshabani@sbmu.ac.ir.
Int Immunopharmacol ; 113(Pt B): 109470, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36435059
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Supressoras Mieloides / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Supressoras Mieloides / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article